- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ISG posts healthy quarter, inks Philips deal
ISG Technologies recorded healthy gains in revenue during its first quarter, which is traditionally the software developer’s weakest revenue-generating period. Revenue grew 10%, while net income also climbed during the quarter (end-September).For
ISG Technologies recorded healthy gains in revenue during its first quarter, which is traditionally the software developers weakest revenue-generating period. Revenue grew 10%, while net income also climbed during the quarter (end-September).
For the period, the Mississauga, Ontario-based firm reported revenue of $5.8 million (U.S.), compared with $5.3 million last year. Net income grew to $187,000, compared with $5800 in 1997.
In other ISG news, the company has signed a 10-year software development agreement with Philips Medical Systems. ISG will supply the Shelton, CT-based company with various medical imaging products and custom engineering services. Specifically, ISG will continue to develop image viewing, image processing, and filming software for the primary console for the modality vendors Gyroscan NT MRI scanner. It will also provide ISG services for other Philips medical products in the future.
Philips, which has maintained a supply relationship with ISG since 1988, also recently signed an agreement to join the Surgical Navigation Network, a consortium of companies working to integrate image-guided surgery technology products. SNN companies have agreed to use the Windows NT-based image-guided surgery software system produced by Surgical Navigation Specialists, a joint venture between ISG and Carl Zeiss (SCAN 9/16/98).
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
